EON Resources vs Arcadia Biosciences
EONR and RKDA side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EONR and RKDA compare
EON Resources is the larger company, worth 29 times as much as Arcadia Biosciences ($13.4M against $466K).
Arcadia Biosciences grew revenue faster over the last twelve months (−12.2% versus −24.6% for EON Resources).
EON Resources keeps more of each dollar of sales as profit, with a net margin of −74.1% compared with −235% at Arcadia Biosciences.
Arcadia Biosciences scores higher on the StockData Score (6 against 3 for EON Resources), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EONR | RKDA |
|---|---|---|
| Size and price | ||
| Market cap | $13.4M | $466K |
| Share price | $0.240 | $0.194 |
| Change, 1 year | −47.5% | −95.0% |
| Change, 5 years | – | −99.7% |
| Beta (5Y) | – | 1.69 |
| Employees | 6 | 8 |
| StockData Score | ||
| Total score | 3 | 6 (better) |
| Valuation score | 3 (better) | 1 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 0 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.9× | 0.1× (better) |
| Fair value | $0.359 | – |
| Margin of safety | 33.1% | – |
| Growth | ||
| Revenue growth (TTM) | −24.6% | −12.2% (better) |
| Revenue growth, 5Y average | – | −9.6% |
| Profitability | ||
| Gross margin | – | 34.6% |
| Operating margin | −116% | −80.1% (better) |
| Net margin | −74.1% (better) | −235% |
| Return on equity | −65.0% | – |
| Return on invested capital | −24.5% | – |
| Financial health | ||
| Interest coverage | −9.3× | – |
| Current ratio | 0.16 | 3.49 (better) |
| Altman Z-score | −1.21 (better) | −69.78 |
| Piotroski F-score | 2 | 3 (better) |
| Dividends and buybacks | ||
| Buyback yield | −11.0% | – |
| Shareholder yield | −11.0% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 9.7% | 8.8% |
| Held by insiders | 11.7% | 1.4% |
| Insider net buying, 12 months | $0 | – |
| Short interest, % of float | 5.9% | 4.9% |
Go deeper
- EONR stock overview
- EONR income statement
- EONR valuation and score
- RKDA stock overview
- RKDA income statement
- RKDA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.